Latest Developments on:

• Circulating Tumor Cells (CTCs)
• Circulating tumor DNA (ctDNA)
• Circulating miRNAs (cfmiRNAs)
• Exosomes and extracellular vesicles (EVs)
  
  

Novel and established technologies in Liquid Biopsies:

• CTC isolation and detection systems
• Single-cell drug testing
• Epigenetic signatures
  
  

Clinical Applications on:

• Early detection
• Detection of minimal residual disease
• Cancer screening for patient selection
• Monitoring treatment response and drug resistance
• Liquid biopsy as a treatment-selection tool in advanced cancers
• Clinical trials
  
  

Implementation in Clinical Practice:

• Pre-analytical considerations, quality control
• Standardizing Liquid Biopsy for clinical use
• International Public-Private Partnerships on liquid biopsy
• Regulatory Considerations for Utilizing Liquid Biopsies in Drug and Diagnostics Development